<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04485312</url>
  </required_header>
  <id_info>
    <org_study_id>abcxyz</org_study_id>
    <nct_id>NCT04485312</nct_id>
  </id_info>
  <brief_title>Chance to Avoid New Caries by Adding Chlorhexidine to the Preventive Protocol in Adolescent Special Needs</brief_title>
  <official_title>Chance to Avoid New Caries by Adding Chlorhexidine Containing Chemotherapeutic Agent to the Conventional Preventive Protocol for Patients With Special Needs</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Adolescent Special need individuals are most need of easy forms of antibacterial agents, so&#xD;
      in this study, using chemotherapeutic agents like the newly introduced varnish containing&#xD;
      chlorhexidine seems to be a quite promising tool for local delivery to patients with special&#xD;
      needs . Chlorhexidine is a wide spectrum very effective bactericidal used for years against&#xD;
      the oral flora while fluorides are well known with their antibacterial ability. This may be&#xD;
      an excellent way to reduce the risk assessment in adolescent special needs patients.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Participants will be divided into two groups according to the tested regimen, where (A1)&#xD;
      represents participants exposed to risk based conventional protocol, (A2) represents&#xD;
      participants exposed to chlorhexidine containing varnish and risk based conventional&#xD;
      preventive protocol. The study will be carried over a period of 10 months (one academic&#xD;
      year), the study will be divided into three phases Phase I: Information of the Cariogram&#xD;
      parameters (caries experience, diet content, diet frequency, plaque amount, mutans&#xD;
      streptococci, fluoride program, saliva secretion and saliva buffer capacity) will be&#xD;
      collected, which will be used to generate the individual caries profile, based on which the&#xD;
      participants will be divided into 2 risks groups. Phase II: Risk based preventive program&#xD;
      will be implemented including the restorative part. Phase III: At the end of 10 months,&#xD;
      caries profile will be generated again&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 15, 2020</start_date>
  <completion_date type="Actual">July 15, 2021</completion_date>
  <primary_completion_date type="Actual">July 15, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>chance to avoid new caries</measure>
    <time_frame>10 months</time_frame>
    <description>% of the green sector in the cariogram</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">22</enrollment>
  <condition>Disabilities Multiple</condition>
  <arm_group>
    <arm_group_label>caries preventive protocol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>preventive protocol for special needs ( tooth brushing , topical fluoride and mouth wash)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>chlorhexidine varnish added to the caries preventive protocol</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>chlorhexidine varnish preventive caries protocol for special needs</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>preventive protocol</intervention_name>
    <description>preventive protocol</description>
    <arm_group_label>caries preventive protocol</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>chlorhexidine added to the preventive protocol</intervention_name>
    <description>chlorhexidine varnish added to the preventive protocol</description>
    <arm_group_label>chlorhexidine varnish added to the caries preventive protocol</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Clinical diagnosis of disability like : autism and down syndrome.&#xD;
&#xD;
          -  Must be able to open his/her mouth for varnish application&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  systemically unhealthy patients with fetal diseases&#xD;
&#xD;
          -  Age below 13 and above 18&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>13 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>katreen tawfik, master</last_name>
    <role>Principal Investigator</role>
    <affiliation>cairo U</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>School</name>
      <address>
        <city>Giza</city>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>July 18, 2020</study_first_submitted>
  <study_first_submitted_qc>July 23, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">July 24, 2020</study_first_posted>
  <last_update_submitted>August 11, 2021</last_update_submitted>
  <last_update_submitted_qc>August 11, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>Katreen Tawfik</investigator_full_name>
    <investigator_title>principal investigator</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chlorhexidine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>publications in journal</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_time_frame>1 year</ipd_time_frame>
    <ipd_access_criteria>online access</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

